
Despite GMP deficiencies, EMA reinstates GMP certificate for Ranbaxy's Toansa facility, citing no threat to public health.

Despite GMP deficiencies, EMA reinstates GMP certificate for Ranbaxy's Toansa facility, citing no threat to public health.

Bayer extends its CEO contract with Marijn Dekkers until 2016.

Malvern Instruments will acquire the MicroCal business from GE Healthcare Life Sciences.

Genia's DNA-sequencing platform will strengthen Roche's pipeline.

EMA publishes revised guideline on the acceptability of names for drugs.

FDA issues a Form 483 to Wockhardt for quality issues at Morton Grove, IL facility.

Teva assigns new executive positions and acquires Labrys Biologics.

Alexion initiates a voluntary nationwide recall of certain lots of soliris (eculizumab) concentrated solution for intravenous infusion because of visible particulate matter in a single lot.

AMRI adds commercial-scale sterile injectable manufacturing capabilities with acquisition of Oso Biopharmaceuticals.

Aastrom acquires Sanofi's CTRM business unit for $6.5 million.

PharmaCell has finalized its purchase of the cell therapy production facility from TiGenix.

FDA launches openFDA to provide easy access to FDA public data.

Repligen acquired Refine Technology and its Alternating Tangential Flow system for continuous bioprocessing.

Provence Technologies? strengthens its expertise in therapeutic chemistry with acquisition of Synprosis.

Brunei harnesses its rich biodiversity and the growing halal market in a bid to develop its pharmaceutical sector.

Bend Research installs its first commercial-scale spray dryer at its Oregon facility.

Protecting intellectual property rights is vital to biopharmaceutical innovation.

The European Pharmacopoeia Commission re-evaluates its policy on the development of monographs for finished drug products.

DCAT's Sharp Sourcing 2014 educational program offers pharmaceutical and biopharmaceutical companies a forum to gain best practice insights in sourcing and procurement.

John Hopkins and UCSF-Stanford join FDA?s Centers of Excellence in Regulatory Science and Innovation.

FDA finalizes guidance on expedited programs for new drug approvals for treatment of serious and life-threatening conditions.

The CPhI report warns that Turkey's dynamism is being restricted by the current government reimbursement model.

ASCO meeting attendees give artistic interpretations of cancer journeys in the form of public Hope Murals.

Bristol-Myers Squibb announced collaborations with CytomX on probodies and with Incyte in an immunotherapy clinical trial.

The 11th Annual Global Biomanufacturing Study includes a global analysis of 238 biomanufacturers and 178 suppliers in 31 countries.

The Bulk Pharmaceuticals Task Force asks FDA to respond to concerns about reduction in API facility compliance inspections.

Actavis develops a solid dosage manufacturing and packing facility at its Manati site in Puerto Rico.

EquipNet announced its 15th year of supplying asset management services.

DPx Holdings B.V. donated $110,000 to more than 20 different hospitals and organizations across the globe.

The EDQM grants Gnosis a CEP for teicoplanin, a true fermentation glycopeptide antibiotic produced by actinoplanes teichomyceticus strains.